OPKO Health, Inc. 13D and 13G filings for GeneDx Holdings Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-04-20 4:26 pm Purchase |
2023-04-12 | 13D | GeneDx Holdings Corp. WGS |
OPKO HEALTH INC. OPK |
3,558,602 14.300% |
701,459![]() (+24.55%) |
Filing |
2023-02-03 4:10 pm Purchase |
2023-01-26 | 13D | GeneDx Holdings Corp. WGS |
OPKO HEALTH INC. OPK |
2,857,143 11.600% |
432,900![]() (+17.86%) |
Filing |
2022-05-09 4:39 pm Purchase |
2022-04-29 | 13D | GeneDx Holdings Corp. WGS |
OPKO HEALTH INC. OPK |
2,424,242 21.200% |
2,424,242![]() (New Position) |
Filing |